Dionysos Slaga

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Top Venues

Science translational medicine

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ji Li, Peiyin Wang, Dionysos Slaga, Kendra N Avery, Ke Liu, Suzanne Schubbert, Rajat Varma, Eugene Y Chiang, Klara Totpal, Matthew J Bernett, Patrick G Holder, Teemu T Junttila
IL-15/IL-15Rα-Fc fusion protein XmAb24306 potentiates activity of CD3 bispecific antibodies through enhancing T cell expansion. Molecular cancer therapeutics (2024)
Ji Li, Dionysos Slaga, Jennifer Johnston, Teemu T Junttila
IMiDs augment CD3-bispecific antibody induced CD8+ cell cytotoxicity and expansion by enhancing IL-2 production. Molecular cancer therapeutics (2023)
Ji Li, Robert Piskol, Ryan Ybarra, Ying-Jiun J Chen, Jason Li, Dionysos Slaga, Maria Hristopoulos, Robyn Clark, Zora Modrusan, Klara Totpal, Melissa R Junttila, Teemu T Junttila
CD3 bispecific antibody-induced cytokine release is dispensable for cytotoxic T cell activity. Science translational medicine 11 (508) (2020)
Dionysos Slaga, Diego Ellerman, T Noelle Lombana, Rajesh Vij, Ji Li, Maria Hristopoulos, Peiyin Wang, Jennifer Johnston, Amy Shelton, Elaine Mai, Kapil Gadkar, Amy A Lo, James T Koerber, Klara Totpal, Rodney Prell, Genee Lee, Christoph Spiess, Teemu T Junttila
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3. Science translational medicine 10 (463) (2019)